The American Clinical Chemistry Analyzers market is estimated to grow at a CAGR of 5.2% from 2014 to 2019. Countries, such as the U.S., Canada, Mexico, Chile and Rest of Americas (RoA) are covered in this report.
The Americas is the largest market for clinical chemistry analyzers due to the factors such as; increasing healthcare expenditure, growing aging population, rising prevalence to various infectious diseases such as; tuberculosis, malaria, hepatitis, Rise in Rental Agreements, Also, increasing medical insurance in the U.S., and inclination towards laboratory automation in the region and developing infrastructure facilities would create a growing need for automated laboratories and analyzers as well.
Among the major countries covered, the U.S. contributed the major share, followed by Canada, while Chile is expected to grow with highest CAGR during the forecast period.
The report, “Americas Clinical Chemistry Analyzers Market” is broadly classified on the basis of type, technology, and end-user. On the basis of types, the market includes - Semi-automated and Fully Automated Analyzers. Further, the Fully Automated Clinical Chemistry Instruments market is segmented into Entry Level, Medium Throughput, Large High Throughput, and Ultra-Large High Throughput Analyzers on the basis of tests per hour. The market in terms of technology covers wet and dry chemistry.
The market is also segmented on the basis of major end-users of this market, such as academic research institutes, diagnostic laboratories, hospitals, among other end-users.
The report has profiled the leading players of this market along with the developments (New product launches and partnerships, agreements, collaborations, and joint ventures) undertaken by the companies over the past few years, and strategies adopted by them to sustain and strengthen their position in the clinical chemistry analyzers market. Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup (France), Mindray (China), and Horiba (Japan), are some of the key players operating in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the stationary cycle market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers and can be customized too, as follows:
Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Americas clinical chemistry analyzers market. Usage pattern/ penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for Americas clinical chemistry instruments/analyzers across countries, exploit new distribution channels, new clientele base and different pricing policies.
Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments decisions in the Americas clinical chemistry analyzers market. Detailed description regarding the related and unrelated diversification pertaining to this market.
Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecast till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the Americas: Clinical Chemistry Analyzers market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook